Patent · US Active

Formulations and methods for delivery of growth factor analogs

US7671012B2 · kind B2 · utility

13Cited by

53References

2Claims

0Family size

Assignee

BioSurface Engineering Technologies, Inc. · US

Inventors

Paul O. Zamora · Gaithersburg, US
Sarah Campion · Danville, US

Key dates

Filing date	Feb 23, 2006
Grant date	Mar 2, 2010
Priority date	—
Expiry date	Mar 30, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/414
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Formulations, kits and methods for bone or cartilage repair, including treatment of osteogenic defects, including formulations of synthetic heparin-binding growth factor analogs, non-ionic polymers, gelling agents and calcium-containing agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.